Cancer Research Technology and AstraZeneca expand successful multi-project cancer metabolism alliance in London, Cambridge and Manchester.
CRT, Cancer Research UK’s commercialisation company, and AstraZeneca have extended their multi-project cancer metabolism alliance for a further two years.
7 Mar 2013